Meta synthesis of communication of diseases between cancer patients and minor children
10.3760/cma.j.cn115682-20250401-01634
- VernacularTitle:癌症患者与未成年子女疾病沟通质性研究的Meta整合
- Author:
Xiaoyu GUO
1
;
Yingying LI
;
Yuli LI
;
Mengdi LIU
;
Yanqiu GAO
;
Zhenmei ZHANG
Author Information
1. 山东第一医科大学附属省立医院专科护理门诊，济南 250010
- Publication Type:Journal Article
- Keywords:
Neoplasms;
Minor children;
Experience;
Qualitative research;
Meta-synthesis
- From:
Chinese Journal of Modern Nursing
2025;31(34):4691-4698
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To conduct evidence synthesis on disease communication between parents and their minor children from the perspective of parents with cancer, so as to provide information for clinical healthcare providers to deliver improved health education to patients and their children.Methods:Computer retrieval was implemented in PubMed, CINAHL, Embase, Web of Science, PsycINFO, Cochrane Library, ProQuest, China National Knowledge Infrastructure, and Wanfang Data. The search period was from January 1, 2000 to March 6, 2025. The literature was assessed according to the Joanna Briggs Institute (JBI) Center for Evidence-Based Health Care Quality Assessment Criteria for Qualitative Research. The JBI aggregative integration method was employed for the Meta-synthesis.Results:A total of nine articles were included. Thirty-two results were extracted, divided into ten categories, and integrated into five results, namely willingness to communicate illness, factors influencing communicating willingness, disease communication strategies, supporting children's coping, and perceptions of illness information.Conclusions:Disease communication between cancer parents and their minor children is influenced by multiple factors and exhibits complex diversity. Healthcare providers should fully understand and accurately recognize the distinct approaches of parents with cancer, offering guidance, advice, and encouragement whenever possible, and should dynamically provide timely medical support and assistance tailored to the evolving needs of patients throughout different stages of their disease treatment.
